Insights from the first patients treated with PD1 and PD-L1 immune checkpoint inhibitors for their metastatic colorectal cancer reinforced and built on successful clinical trial results.
The study links specific TSC1/2 gene mutations to distinct disease trajectories to help guide patient care and surveillance for this multi-faceted disease.
Dr. Vince, an inventor and scientist, leads Cleveland Clinic Innovations and chairs the Department of Biomedical Engineering.
The Global Center for Pathogen Research & Human Health will bring together a research team to broaden understanding of viral pathogens and the human immune response toward preparing and protecting against future public health threats.
Learn MoreThe Florida Research & Innovation Center in Port St. Lucie, Florida, is a cutting-edge research institute dedicated to advancing medicine and saving lives through groundbreaking research, discovery and innovation.
Learn MoreLerner Research Institute’s state-of-the-art cores and facilities offer investigators advanced technologies, equipment and expertise to support laboratory, translational and clinical research.
Learn MoreSince Cleveland Clinic’s founding in 1921, research and education have been integral parts of the hospital’s mission.
More About UsThe future of health starts with your support. Donations supply researchers with the tools, space and staff they need to think big.
Give to Cleveland Clinic